HomeTechnical SetupAMBALALSA
21tech score
/ 100

Ambalal Sarabhai (AMBALALSA) — Technical Setup

₹39.97 -3.17%   Range Normal Volatility Strong bearish

As of 2026-09-18 close Sector: Pharma Pharmaceuticals

Summary

Ambalal Sarabhai is in a range on the daily chart. RSI(14) is 44.3, MACD is below its signal line, ADX reads 24. Volume in the latest session was 1.5× its 20-day average. Over three months it has outperformed the Nifty 50 by 28.8 percentage points. Nearest support is ₹38.50 and resistance ₹40.40. Its technical score is 21/100 (strong bearish).

Trend (daily)
Neutral
Trend (weekly)
Trend (monthly)
RSI (14)
44.29
MACD
Bearish
ADX (14)
23.65
Volume vs 20d avg
1.52×
Support
₹38.50 (−3.7%)
Resistance
₹40.40 (+1.1%)
RS vs Nifty (3M)
+28.75%
RS rating

🧮 How the 21/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend3/20
  • Close above 20-day EMA (-4.39)0/3
  • 20-day EMA above 50-day EMA3/3
  • 50-day EMA above 200-day EMA0/3
  • Close above 200-day SMA0/3
  • SuperTrend (10,3) pointing up0/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (23.65)0/3
  • Weekly trend up (above a rising 30-week average)0/2
Momentum6/20
  • RSI(14) in the bullish zone (55-70 best) (44.29)2/6
  • MACD line above its signal line0/4
  • MACD line above zero (-0.30)0/3
  • 12-day rate of change positive (-8.99)0/3
  • Stochastic %K above %D2/2
  • Outperforming the Nifty 50 over 3 months (28.75)2/2
Volume0/20
  • On-balance volume rising over 20 sessions0/5
  • Chaikin Money Flow (20) positive (-0.19)0/5
  • More volume on up days than down days (20 sessions) (0.50)0/5
  • Close above 20-day VWAP (-7.15)0/5
Volatility7/20
  • Daily range (ATR%) contained — ≤2.5% scores full (5.93)2/6
  • Price in the upper half of its Bollinger Bands (0.13)0/5
  • Shallow drawdown from the 52-week high (-20.03)1/5
  • Volatility contracting (20-day volatility below its 6-month median) (28.20)4/4
Support / Resistance5/20
  • Room to the next resistance (≥8% scores full) (1.08)0/5
  • Support close below (a tight, definable stop) (3.68)5/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-20.03)0/5

🧭 Regime: Range

Normal Volatility — Bollinger width is in the 50th percentile of the last six months.

Suits: Mean reversion / range trading. No directional edge: buy near range support, sell near resistance, and treat breakouts with suspicion until volume confirms them.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the Bollinger Band Reversion rules for AMBALALSA — close below the lower bollinger band (20,2) while above the 200-day sma.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly
Weekly
Daily◆ Neutral44.29-0.68

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: —, weekly ADX —.

📶 Volume & VWAP

Relative volume
1.52×
5d / 20d volume
0.45×
Volume ROC (10d)
-24.34%
Up/down volume
0.50×
OBV (20d)
Falling / flat
Chaikin MF (20)
-0.19
VWAP 20d
₹43.05 (-7.15%)
VWAP 50d
₹42.05 (-4.95%)
Anchored VWAP · 52W low
₹42.38 (-5.69%)
Anchored VWAP · 52W high
₹45.12 (-11.41%)
Anchored VWAP · YTD
₹39.22 (+1.91%)
Avg turnover (20d)
₹0.25 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal.

💪 Relative strength

vs Nifty 1M
-10.67%
vs Nifty 3M
+28.75%
vs Nifty 6M
vs Nifty 1Y
RS rating
Mansfield RS
vs Pharma index 3M
+17.75%
vs sector peers 3M
+16.06%

AMBALALSA ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹49.94+24.9%2
Resistance₹46.20+15.6%1
Resistance₹40.40+1.1%1
Close₹39.97
Support₹38.50−3.7%1
Support₹33.59−16.0%1
Support₹30.45−23.8%4

52-week range: ₹30.15 – ₹49.98 (-20.03% from the high).

🌀 Fibonacci

Measuring the up-swing from ₹30.15 (2026-07-23) to ₹49.98 (2026-08-10). Price has retraced 50.5% of it.

RatioPriceDistance
23.6% retracement₹45.30+13.3%
38.2% retracement₹42.40+6.1%
50.0% retracement₹40.06+0.2%S/R confluence nearest
61.8% retracement₹37.73-5.6%
78.6% retracement₹34.39-13.9%
127.2% extension₹55.37+38.5%
161.8% extension₹62.23+55.7%
200.0% extension₹69.81+74.7%

Next Fibonacci time zone: 55 sessions from the swing start ≈ 2026-10-09 (approximate — exchange holidays are not modelled).

🕯️ Candlesticks (last 5 sessions)

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

✅ Screens AMBALALSA passes today

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
AUROPHARMAAurobindo Pharma Limited ₹1,734 +2.60% 94 Uptrend 84.00
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited ₹102.13 +0.40% 85 Strong Uptrend 86.00
ACUTAASAcutaas Chemicals Limited ₹3,440 +3.78% 85 Uptrend 93.00
KOPRANKopran Limited ₹277.60 +3.35% 85 Strong Uptrend 96.00
BAFNAPHBafna Pharmaceuticals Limited ₹317.20 +1.99% 84 Strong Uptrend 98.00
KILITCHKilitch Drugs (India) Limited ₹191.45 +1.47% 84 Uptrend 63.00
CAPLIPOINTCaplin Point Laboratories Limited ₹2,749 +5.85% 83 Uptrend 83.00
GLANDGland Pharma Limited ₹2,962 +1.86% 83 Strong Uptrend 91.00
JUBLPHARMAJubilant Pharmova Limited ₹1,065 +5.27% 80 Strong Uptrend 64.00
STARStrides Pharma Science Limited ₹1,220 +1.63% 80 Strong Uptrend 81.00
🔗 More on AMBALALSA

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ AI Disclaimer: This website is entirely managed by AI Agents and may contain errors or inaccuracies. Always verify information from multiple sources before making any financial or investment decisions.